Co-delivery of siRNAs and anti-cancer drugs using layered double hydroxide nanoparticles

被引:264
|
作者
Li, Li [1 ]
Gu, Wenyi [1 ,2 ,3 ]
Chen, Jiezhong
Chen, Weiyu [1 ]
Xu, Zhi P. [1 ]
机构
[1] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia
[2] Univ Queensland, Sch Biomed Sci, St Lucia, Qld 4072, Australia
[3] Univ Wollongong, Fac Sci Med & Hlth, Wollongong, NSW 2522, Australia
关键词
Co-delivery system; Layered double hydroxide; Electrostatic assembly; Apoptosis; MULTIDRUG-RESISTANT CANCER; 5-FLUOROURACIL; DOXORUBICIN; THERAPY; APOPTOSIS; EFFICACY; CELLS; NANOCARRIERS; CHEMOTHERAPY; MECHANISMS;
D O I
10.1016/j.biomaterials.2013.12.095
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In this research we employed layered double hydroxide nanoparticles (LDHs) to simultaneously deliver an anticancer drug 5-fluorouracil (5-FU) and Allstars Cell Death siRNA (CD-siRNA) for effective cancer treatment. The strategy takes advantage of the LDH anion exchange capacity to intercalate 5-FU into its interlayer spacing and load siRNA on the surface of LDH nanoparticles. LDH nanoparticles have been previously demonstrated as an effective cellular delivery system for 5-FU and siRNA separately in various investigations. More excitedly, the combination of CD-siRNA and anticancer drug 5-FU with the same LDH particles significantly enhanced cytotoxicity to three cancer cell lines, e.g. MCF-7, U2OS and HCT-116, compared to the single treatment with either CD-siRNA or 5-FU. This enhancement is probably a result of coordinate mitochondrial damage process. Thus, the strategy to co-deliver siRNA and an anticancer drug by LDHs has great potential to overcome the drug resistance and enhance cancer treatment. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3331 / 3339
页数:9
相关论文
共 50 条
  • [1] Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy
    Qi, Shan-Shan
    Sun, Jia-Hui
    Yu, Hao-Han
    Yu, Shu-Qin
    DRUG DELIVERY, 2017, 24 (01) : 1909 - 1926
  • [2] Co-delivery nanoparticles of doxorubicin and chloroquine for improving the anti-cancer effect in vitro
    Sun, Jia-Hui
    Ye, Chong
    Bai, En-He
    Zhang, Ling-Ling
    Huo, Shao-Jie
    Yu, Hao-Han
    Xiang, Su-Yun
    Yu, Shu-Qin
    NANOTECHNOLOGY, 2019, 30 (08)
  • [3] Multifunctional System for Image-Guided Co-delivery of siRNA and Anti-Cancer Drugs
    Guo, Yi
    Huang, Sijun
    Zhang, Junrong
    Yang, Jie
    Wang, Shunuo
    Zhang, Liqiang
    Xu, Li
    CANCER SCIENCE, 2018, 109 : 387 - 387
  • [4] Conjugation of two complementary anti-cancer drugs confers molecular hydrogels as a co-delivery system
    Mao, Lina
    Wang, Huaimin
    Tan, Ming
    Ou, Lailiang
    Kong, Deling
    Yang, Zhimou
    CHEMICAL COMMUNICATIONS, 2012, 48 (03) : 395 - 397
  • [5] Efficient co-delivery of neo-epitopes using dispersion-stable layered double hydroxide nanoparticles for enhanced melanoma immunotherapy
    Zhang, Ling-xiao
    Xie, Xi-xiu
    Liu, Dong-qun
    Xu, Zhi Ping
    Liu, Rui-tian
    BIOMATERIALS, 2018, 174 : 54 - 66
  • [6] Delivery of Anti-Cancer Drugs Using Nanocarriers
    Lally, B.
    Gettens, R.
    Sani, S.
    2013 39TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC 2013), 2013, : 261 - +
  • [7] Co-Delivery of Drugs and Genes Using Polymeric Nanoparticles for Synergistic Cancer Therapeutic Effects
    Li, Yi
    Thambi, Thavasyappan
    Lee, Doo Sung
    ADVANCED HEALTHCARE MATERIALS, 2018, 7 (01)
  • [8] Layered Double Hydroxide Nanoparticles for Efficient Gene Delivery for Cancer Treatment
    Senapati, Sudipta
    Sarkar, Tanmoy
    Das, Parimal
    Maiti, Pralay
    BIOCONJUGATE CHEMISTRY, 2019, 30 (10) : 2544 - 2554
  • [9] Silica Nanoparticles: A Promising Vehicle for Anti-Cancer Drugs Delivery
    Aparna, T. Naga
    Kumar, Rohit
    Ali, Shah Raj
    Patel, Dhaval J.
    Julekha, Kazi
    Begum, Touseef
    Bala, Jyoti
    Kumar, Pawan
    AAPS PHARMSCITECH, 2025, 26 (01):
  • [10] Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
    Kim, Min Woo
    Jeong, Hwa Yeon
    Kang, Seong Jae
    Jeong, In Ho
    Choi, Moon Jung
    You, Young Myoung
    Im, Chan Su
    Song, In Ho
    Lee, Tae Sup
    Lee, Jin Suk
    Lee, Aeju
    Park, Yong Serk
    THERANOSTICS, 2019, 9 (03): : 837 - 852